Hamza Celik

Critic
DISC Type : C

Director, Hematology-Oncology Drug Discovery at Incyte

Wilmington, Delaware, United States

Overview

Hamza Celik is the Director of Hematology-Oncology Drug Discovery at Incyte, where he leads multi-disciplinary teams on small molecule drug discovery programs from initial identification to IND. His expertise is rooted in his academic research at Washington University and a Ph. D. from CNRS, complemented by a recent PocketMBA.

Outside of his direct research, Hamza is a supportive leader who actively mentors scientists and champions rising talent in the field. He shows a keen interest in the intersection of science and business, following publications like the Harvard Business Review and encouraging recruitment for his growing teams.

Unique fact: Hamzas past research included developing strategies to use CRISPR technology as a "finely-honed molecular scalpel" to edit the epigenome.

Personality Overview

Objective Thinker

Critic

Information Seeker

They like to do things independently and don’t look for support from others.  It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Hematology Drug Discovery
His entire career, from academia to his current Director role at Incyte, has been focused on discovering and developing therapeutics for hematological malignancies.
Epigenetic Research
His postdoctoral and grant-funded research heavily focused on the role of epigenetic modifiers and tumor suppressors in myeloid malignancies.
Scientific Mentorship
He manages and mentors PhD-level scientists, has trained graduate students and postdocs, and publicly supports rising talent in his field.

Media Appearances

Hamza has no verified media appearances

Work History

2-2025
Director, Hematology-Oncology Drug Discovery at Incyte
2-2023 - 2-2025
Associate Director at Incyte
12-2020 - 2-2023
Principal Investigator, Pharmacology at Incyte
7-2018 - 12-2020
Instructor in Medicine at Washington University in St. Louis
12-2013 - 6-2018
Postdoctoral Researcher at Washington University in St. Louis

Education

7-2010 - 10-2013
Molecular Biology from French National Centre for Scientific Research (CNRS)
2009 - 2010
Functional Genomic from University of York

More Information

Social Presence :

Prographics :

Exp : 12 Location : Wilmington, Delaware, United States Job Level : Mid-senior Designation : Director, Hematology-Oncology Drug Discovery at Incyte
URL has been copied!

Insights For Selling To Hamza

During A Call Or A Meeting

DO's

  • Be ready for penetrating questions and critical examination of your pitch
  • Don’t forget to mention how you compare to competition on both features and pricing
  • Tell them what ROI they can expect

DONT's

  • Don’t rush them till they have clearly gotten all the necessary information
  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Avoid pushing them too much to involve other stakeholders unless it is critical

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Hamza is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Hamza

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Hamza move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Hamza take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Hamza

Personality Compatibility


Other Incyte Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.